At a glance
ClinicalIndex Comparison RecordEarly Ph 1Completed· 22 enrolled
Drug / intervention
Correction of abnormally fertilized oocytesprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Treatment of Abnormally Multinucleated Zygotes Before Before Division Starting.
In Brief
A Early Phase 1 clinical trial evaluating Correction of abnormally fertilized oocytes for Infertility. Completed, enrolled 22 participants across 2 sites in 2 countries.
Detailed Summary
In this newly developed protocol, and idea, is to manage those abnormally developed zygotes from different ART procedures. The investigators developed the plan and requirements needed to select the target extra nucleus or pronuclei to be extruded from fertilized egg in order to maintain developing healthy normal embryo.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfertility
CountriesBahrain, Egypt
Collaborators--
Timeline
Early Ph 1CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartJun 2014
First PostedFeb 2015
Primary CompletionSep 2015
TodayJul 2026
First PostedFeb 9, 2015
Enrollment StartJun 1, 2014
Primary CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 11.4 years ago
Interventions
Correction of abnormally fertilized oocytesprocedure
Removing of extra developed nucleus from fertilized oocyte.